Amarin | AMRN - Devedores Comerciais





Devedores Comerciais Alterar Data
AbbVie USD 12.48B 110M 2026-03
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amarin USD 126.83M 477K 2025-12
AstraZeneca USD 18.86B 972M 2026-06
BioCryst Pharmaceuticals USD 110.76M 3.94M 2026-06
DBV Technologies USD 15.1M 1.05M 2026-03
GlaxoSmithKline GBP 8.07B 137M 2026-06
Halozyme Therapeutics USD 453.33M 4.66M 2026-06
Heron Therapeutics USD 89.59M 8.54M 2025-12
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neurocrine Biosciences USD 887M 118.9M 2026-06
Novartis USD 9.85B 252M 2026-06